Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.

CONCLUSION:  We conclude that COVID-19+ patients with moderate or severe illness benefit from anticoagulation and that apixaban has similar efficacy to enoxaparin in decreasing mortality in this disease. PMID: 33186991 [PubMed - as supplied by publisher]
Source: Thrombosis and Haemostasis - Category: Hematology Authors: Tags: Thromb Haemost Source Type: research